US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class I · High risk Terminated

NP Thyroid 90

Reason Superpotent Drug.

Acella Pharmaceuticals, LLC NDC 42192-331-01 D-1300-2020
Class I · High risk Terminated

NP Thyroid 60

Reason Superpotent Drug.

Acella Pharmaceuticals, LLC NDC 42192-330-01 D-1299-2020
Class I · High risk Terminated

NP Thyroid 30

Reason Superpotent Drug.

Acella Pharmaceuticals, LLC NDC 42192-329-01 D-1298-2020
Class II · Moderate risk Terminated

Doxycycline Hyclate Tablets

Reason Failed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out-of-specification result.

The Harvard Drug Group NDC 0904-0430-04 D-1288-2020
Class II · Moderate risk Terminated

Dextroamphetamine Saccharate

Reason Some bottles may contain mixed strengths of the product.

Teva Pharmaceuticals USA NDC 0555-0973-02 D-1287-2020
Class II · Moderate risk Terminated

Dextroamphetamine Saccharate

Reason Some bottles may contain mixed strengths of the product.

Teva Pharmaceuticals USA NDC 0555-0777-02 D-1286-2020
Class II · Moderate risk Terminated

Dextroamphetamine Saccharate

Reason Some bottles may contain mixed strengths of the product.

Teva Pharmaceuticals USA NDC 0555-0971-02 D-1285-2020
Class III · Low risk Terminated

Zilretta

Reason Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded

Flexion Therapeutics, Inc. NDC 70801-003-01 D-1376-2020
Class II · Moderate risk Terminated

Doxycycline Hyclate Tablets

Reason Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).

American Health Packaging D-1293-2020
Class II · Moderate risk Ongoing

Maximum Strength Lidocaine Cold & Hot Patch

Reason CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Wuhan Bingbing Pharmaceutical Co., Ltd. NDC 66902-218-05 D-1280-2020
Class II · Moderate risk Ongoing

Mencaine

Reason CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Wuhan Bingbing Pharmaceutical Co., Ltd. NDC 53225-1090-1 D-1279-2020
Class II · Moderate risk Ongoing

LidoPro

Reason CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Wuhan Bingbing Pharmaceutical Co., Ltd. NDC 53225-1023-1 D-1278-2020
Class II · Moderate risk Ongoing

LidoPatch

Reason CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Wuhan Bingbing Pharmaceutical Co., Ltd. NDC 10882-527-01 D-1277-2020
Class II · Moderate risk Terminated

EcoLips Sport Lip Balm

Reason Superpotent Drug: The active ingredient, avobenzone, is used at 5% which is higher than the allowable 3% in the sunscreen formula per FDA sunscreen regulations.

Eco Lips Inc D-1310-2020
Class II · Moderate risk Terminated

Estriol USP Micronized 5 G

Reason Failed impurities/ degradation specifications: Out of specification for organic impurities.

Triova Pharmaceuticals LLC NDC 71092-9977-02 D-1284-2020
Class II · Moderate risk Terminated

Doxycycline Hyclate tablets USP

Reason Failed dissolution specifications

PD-Rx Pharmaceuticals, Inc. NDC 55289-866-06 D-1276-2020
Class III · Low risk Terminated

Gabapentin Tablets USP

Reason Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.

InvaGen Pharmaceuticals, Inc. NDC 76282-405-05 D-1272-2020
Class III · Low risk Terminated

Ethacrynic Acid Tablets USP

Reason Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.

West-Ward Columbus Inc D-1282-2020
Class II · Moderate risk Terminated

Doxycycline Hyclate Tablets USP

Reason Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.

West-Ward Columbus Inc NDC 0143-2112-50 D-1274-2020
Class II · Moderate risk Terminated

Sterile Curcumin 50mg/mL

Reason Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

BIOTA Biosciences LLC D-1330-2020
Class II · Moderate risk Terminated

Sterile Cannabidiol

Reason Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

BIOTA Biosciences LLC D-1329-2020
Class II · Moderate risk Terminated

Sterile Cannabidiol

Reason Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

BIOTA Biosciences LLC D-1328-2020
Class II · Moderate risk Terminated

Sterile Curcumin

Reason Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

BIOTA Biosciences LLC D-1327-2020
Class II · Moderate risk Terminated

Sterile Cannabidiol

Reason Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

BIOTA Biosciences LLC D-1326-2020
Class II · Moderate risk Terminated

Carbamazepine Tablets

Reason Failed Dissolution Specifications

Torrent Pharma Inc. NDC 13668-268-05 D-1317-2020